Veradermics, Incorporated
MANE
$126.89
$7.526.30%
NYSE
| 03/31/2026 | 12/31/2025 | 03/31/2025 | |||
|---|---|---|---|---|---|
| Net Income | -27.23M | -21.85M | -12.40M | ||
| Total Depreciation and Amortization | -- | -- | -- | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 5.81M | 820.00K | 559.00K | ||
| Change in Net Operating Assets | 251.00K | -2.60M | -1.48M | ||
| Cash from Operations | -21.17M | -23.63M | -13.32M | ||
| Capital Expenditure | -- | -5.00K | -19.00K | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -101.30M | -109.77M | -15.73M | ||
| Cash from Investing | -101.30M | -109.78M | -15.75M | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | 269.11M | -- | -- | ||
| Repurchase of Common Stock | -- | -1.05M | -- | ||
| Issuance of Preferred Stock | -- | 151.00M | 8.42M | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -- | -437.00K | -- | ||
| Cash from Financing | 269.11M | 149.51M | 8.42M | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 146.65M | 16.11M | -20.64M | ||